LXEO
Lexeo Therapeutics, Inc. Common Stock
Nasdaq · usd
Lexeo Therapeutics, Inc. Common Stock (LXEO) trades at $2.73 (-2.68%) as of 2:21:30 PM EDT on Oct 26, 2026, -17.82% over the past month. Market cap is $229.85M, with 9.0 days to cover in short interest.
Stock performance
How Lexeo Therapeutics, Inc. Common Stock (LXEO) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.86%
- 1W
- -1.45%
- 1M
- -17.82%
- YTD
- -72.61%
- 1Y
- -72.36%
- 52-wk range
- $2.55 – $10.99
Key statistics
Today's trading snapshot for LXEO: day range, open, previous close, volume and market cap.
- Day range
- $2.68 – $2.83
- Open
- $2.80
- Prev close
- $2.80
- Volume
- 603.35K
- Market cap
- $229.85M
- Shares out
- 82.05M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Lexeo Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 0.98
- P/FCF
- —
- ROE
- -37.1%
- ROA
- -34.2%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Lexeo Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Acquisition consideration sharesSep 29, 2026
Each outstanding share of Mantle capital stock ... was converted into the right to receive ... $3,000,000 in shares of Lexeo common stock.
- Acquisition consideration sharesSep 22, 2026
Each outstanding share of Mantle capital stock ... will be converted into the right to receive an aggregate upfront purchase price consisting of: (i) $5,300,000 in cash, subject to certain adjustments; and (ii) $3,000,000 in shares of Lexeo common stock.
- Investor presentationAug 12, 2026
On August 12, 2026, the Company posted on its website an updated corporate presentation (the "Corporate Presentation"). The Corporate Presentation will be used from time to time in meetings with investors and analysts.
- Annual meeting resultsJun 29, 2026
On June 25, 2026, Lexeo Therapeutics, Inc. held its virtual 2026 Annual Meeting of Stockholders. The stockholders voted on the following proposals at the Annual Meeting: Proposal 1. Election of Class III Directors... The Company's stockholders elected the persons listed below as Class III Directors... The final voting results are as follows: [voting table with FOR, WITHHELD, BROKER NON-VOTE columns]
- Investor presentationJun 15, 2026
Also on June 15, 2026, the Company posted on its website an updated corporate presentation (the "Corporate Presentation"). The Corporate Presentation will be used from time to time in meetings with investors and analysts.
LXEO short interest
How heavily LXEO is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 9.0
- Short interest
- 19.25M
- Avg volume
- 2.13M
As of · reported to FINRA twice monthly.
LXEO news
The latest news and headlines about Lexeo Therapeutics, Inc. Common Stock (LXEO).
- Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACMpositiveGlobeNewswire Inc.· Oct 19, 2026
- Lexeo Therapeutics to Participate in the Chardan Healthcare ConferencepositiveGlobeNewswire Inc.· Oct 8, 2026
- Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)positiveGlobeNewswire Inc.· Oct 1, 2026
- Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic CardiomyopathypositiveGlobeNewswire Inc.· Jan 12, 2026
- Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene TherapypositiveGlobeNewswire Inc.· Jan 8, 2026
Frequently asked questions
What is the Lexeo Therapeutics, Inc. Common Stock (LXEO) stock price today?
Lexeo Therapeutics, Inc. Common Stock (LXEO) is trading at $2.73 (-2.68% on the day) as of 2:21:30 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Lexeo Therapeutics, Inc. Common Stock?
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases.
What is the short interest in LXEO?
As of Sep 30, 2026, LXEO has 19.25M shares short and 9.0 days to cover.
What exchange is LXEO listed on?
Lexeo Therapeutics, Inc. Common Stock (LXEO) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of LXEO with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LXEO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.